Literature DB >> 21157214

Thyroid metastasis from primary renal cell cancer on FDG PET/CT.

Aarti Kaushik1, Linh Ho.   

Abstract

We report the PET/CT appearance of metastasis from primary renal cancer to the thyroid in a 52-year-old man with a history of right renal cell carcinoma, status postright nephrectomy, recently presented biopsied-proven metastatic lesion in his left thyroid lobe. Restaging PET/CT study demonstrates a 1.4 × 0.9 cm hypodense, moderately active lesion in the left thyroid lobe with a maximum SUV of 2.8. No other abnormal hypermetabolic lesion is seen in the right renal surgical bed or the remaining body. The patient has subsequently treated with Sutent (Sunitinib).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21157214     DOI: 10.1097/RLU.0b013e3181fef00e

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  18F-FDG PET/CT detects Metastatic Renal Cell Carcinoma Masquerading as Primary Breast Malignancy.

Authors:  Ashwin Singh Parihar; Bhagwant Rai Mittal; Shelvin Kumar Vadi; Rajender Kumar; Kaniyappan Nambiyar; Bishan Radotra; Lileswar Kaman
Journal:  Nucl Med Mol Imaging       Date:  2018-10-27

Review 2.  Metastatic carcinoma to the thyroid gland: a single institution 20-year experience and review of the literature.

Authors:  Parnian Ahmadi Moghaddam; Kristine M Cornejo; Ashraf Khan
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

3.  18F-PET/CT imaging of metastasis to the thyroid gland: Imaging findings and effect on patient management.

Authors:  Giovanni G Millare; Michael Kwon; Beth S Edeiken-Monroe; J Matthew Debnam
Journal:  J Solid Tumors       Date:  2017

4.  Renal cell carcinoma with unusual metastasis to the small intestine manifesting as extensive polyposis: successful management with intraoperative therapeutic endoscopy.

Authors:  Pankaj G Vashi; Elham Abboud; Digant Gupta
Journal:  Case Rep Gastroenterol       Date:  2011-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.